Healthy Skepticism Library item: 7678
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Knudtson ML.
Drug-eluting coronary stents: faith and hope, but no charity.
CMAJ 2007 Jan 16; 176:(2):195-6
http://www.cmaj.ca/cgi/content/full/176/2/195
Abstract:
Judging from the large number of publications on the cost-effectiveness of drug-eluting coronary stents, there is an emerging international consensus that the price tag for the 2 commercially available drug-eluting stents is excessive (approximately $1500 to $3000 per stent in Canada). Why is the price so high? What motivates cardiac centres around the world to continue to buy them in large volumes? The answers to these questions are, in large part, rooted in the very history of the percutaneous coronary intervention (PCI) procedure and in the funding model for the development of new technologies that exists in most of the developed world…
Keywords:
Publication Types:
Comment
Editorial
MeSH Terms:
Coronary Disease/economics
Coronary Disease/therapy*
Cost-Benefit Analysis
Drug Delivery Systems
Drug Industry
Health Policy
Hospital Costs
Hospitals, Private/economics
Hospitals, Public/economics
Humans
Ownership*
Stents/economics*
Stents/utilization*
Notes:
Comment on:
CMAJ. 2007 Jan 16;176(2):185-90.
CMAJ. 2007 Jan 16;176(2):199-205.
Full text:
Free full text
